Bio-Rad Laboratories, Inc. (BIO) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

The Cooper Cos., Inc.

Insulet Corp.

Penumbra, Inc.

Hologic, Inc.

Bruker Corp.

Bio-Rad Laboratories, Inc.

QIAGEN NV

EXACT Sciences Corp.

Revvity, Inc.

Waters Corp.

Teleflex, Inc.

Why is Bio-Rad Laboratories, Inc. ?

Poor long term growth as Net Sales has grown by an annual rate of 2.18% over the last 5 years

The company has declared negative results in Mar'2025 after 3 consecutive positive quarters

PRE-TAX PROFIT(Q) Lowest at USD 82 MM
DEBT-EQUITY RATIO (HY) Highest at 0.43 %
INVENTORY TURNOVER RATIO(HY) Lowest at 1.48 times

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -8.06%, its profits have risen by 69.4% ; the PEG ratio of the company is 0.1

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -8.06% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Bio-Rad Laboratories, Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Bio-Rad Laboratories, Inc. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Bio-Rad Laboratories, Inc.

21.74%

0.24

43.70%

S&P 500

25.41%

0.70

20.15%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.29%

EBIT Growth (5y)

-8.37%

EBIT to Interest (avg)

30.77

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.06

Sales to Capital Employed (avg)

0.30

Tax Ratio

21.31%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

4.97%

ROE (avg)

11.09%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.97

EV to EBIT

26.16

EV to EBITDA

14.73

EV to Capital Employed

0.97

EV to Sales

2.68

PEG Ratio

Dividend Yield

ROCE (Latest)

3.71%

ROE (Latest)

4.65%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

ROCE(HY)

Highest at 2.5%

RAW MATERIAL COST(Y)

Fallen by 1.56% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 1.6 times

DEBTORS TURNOVER RATIO(HY)

Highest at 5.9 times

NET PROFIT(Q)

Highest at USD 211.1 MM

-8What is not working for the Company

INTEREST COVERAGE RATIO(Q)

Lowest at 688.62

OPERATING PROFIT(Q)

Lowest at USD 84.7 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 14.31 %

PRE-TAX PROFIT(Q)

Lowest at USD 48.4 MM

EPS(Q)

Lowest at USD -19.55

Here's what is working for Bio-Rad Laboratories, Inc.

Net Profit

At USD 211.1 MM has Grown at 143.84%

over average net sales of the previous four periods of USD 86.57 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (USD MM)

Net Profit

Highest at USD 211.1 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

Inventory Turnover Ratio

Highest at 1.6 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 5.9 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by 1.56% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Bio-Rad Laboratories, Inc.

Interest Coverage Ratio

Lowest at 688.62

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Pre-Tax Profit

At USD 48.4 MM has Fallen at -38.34%

over average net sales of the previous four periods of USD 78.5 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Operating Profit

Lowest at USD 84.7 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (USD MM)

Operating Profit Margin

Lowest at 14.31 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at USD 48.4 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

EPS

Lowest at USD -19.55

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (USD)